Table 5.

Association between detectable five weeks post‐treatment IgG1, IgG4 and IgE responses against schistosomula antigens and reinfection intensity

Antibody	Antigen	Crude OR (95% CI)	P‐value	Adjusteda OR (95% CI)	P‐value
IgG1	rSmKK7	0.71 (0.34‐1.51)	0.377	1.01 (0.44‐2.30)	0.986
	rSmLy6A	0.27 (0.11‐0.64)	0.004	0.43 (0.16‐1.11)	0.082
	rSmLy6B	0.50 (0.24‐1.07)	0.073	0.80 (0.35‐1.82)	0.592
	rSmTSP7	0.93 (0.43‐1.96)	0.838	1.02 (0.45‐2.31)	0.956
	AWA	0.21 (0.01‐3.58)	0.287	0.62 (0.04‐10.47)	0.741
	SEA	1.59 (0.18‐13.39)	0.668	2.18 (0.23‐19.97)	0.489
IgG4	rSmKK7	0.49 (0.13‐1.73)	0.269	0.58 (0.15‐2.27)	0.439
	rSmLy6A	0.72 (0.19‐2.60)	0.616	0.70 (0.18‐2.76)	0.608
	rSmLy6B	0.37 (0.08‐1.65)	0.193	0.42 (0.09‐2.05)	0.285
	rSmTSP7	1.56 (0.46‐5.16)	0.470	2.17 (0.56‐8.48)	0.265
	AWA	0.89 (0.18‐4.39)	0.885	1.04 (0.19‐5.74)	0.964
	SEA	‐	‐	‐	‐
IgE	rSmKK7	0.74 (0.29‐1.94)	0.546	0.82 (0.29‐2.29)	0.701
	rSmLy6A	0.72 (0.19‐2.59)	0.616	0.54 (0.14‐2.09)	0.371
	rSmLy6B	0.98 (0.45‐2.10)	0.950	1.34 (0.57‐3.12)	0.496
	rSmTSP7	0.68 (0.18‐2.43)	0.551	0.48 (0.12‐1.82)	0.279
	AWA	1.29 (0.59‐2.84)	0.527	1.10 (0.46‐2.62)	0.825
	SEA	1.31 (0.63‐2.78)	0.468	1.19 (0.53‐2.71)	0.671

OR, odds ratio.

^aAdjusted for sex and gender.